Navigation Links
Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications
Date:7/31/2014

NORTHBROOK, Ill., July 31, 2014 /PRNewswire/ -- Astellas has appointed Moyra Knight as the head of corporate and employee communications in the Americas region. Knight will report directly to Jeff Winton, senior vice president, chief communications officer. In this role, Knight will be responsible for developing and leading corporate brand initiatives and reputation management to achieve Astellas' strategic business goals across North and South America. She will also lead corporate social responsibility, executive communications, employee and digital communication and corporate media relations. 

"I am thrilled to add someone with Moyra's reputation and proven track record to the new and growing communications team at Astellas," said Winton. "Moyra's breadth of experience along with her approach to leadership will help accelerate Astellas' brand awareness."

Knight's appointment is the latest phase in the building of the new Corporate Communications team that was launched at Astellas in late 2013 with the appointment of Jeff Winton. Winton came to Astellas from Eli Lilly and Company where he was the Vice President/Head, Global Communications and member of Global Corporate Affairs Leadership Team.

Knight has more than 20 years of communications experience in both the health care and consumer industries. Most recently, she worked at Baxter International Inc. where she held various senior positions within corporate communications. Prior to that, Knight worked at Ogilvy Public Relations Worldwide and Kraft Foods, Inc. where she led various teams focused on consumer marketing, communications, and public affairs. Knight received her undergraduate degree in journalism from the University of Colorado at Boulder.

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS.

Photo - http://photos.prnewswire.com/prnh/20140730/131902
Logo - http://photos.prnewswire.com/prnh/20140416/84970


'/>"/>
SOURCE Astellas
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
2. Astellas and Fujita Health University Discover Neuronal Maturation Deficits in Patients Suffering from Schizophrenia and Bipolar Disorder
3. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
4. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
5. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
6. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
7. Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
8. Astellas to Drive PGA TOURs New Womens Initiative
9. PGA TOUR Celebrates Official Launch of the Astellas Presents Executive Womens Day Program
10. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
11. Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... FLINT, Mich. , Aug. 7, 2017 Diplomat ... appointment of Joel Saban as president, effective Aug. ... Paul Urick has decided to pursue other interests and ... period. "During his tenure, Paul has served us in multiple ... Burman,s Specialty Pharmacy in Jun. 2015 and has provided decisive, ...
(Date:8/7/2017)... International plc (NASDAQ: ENDP ) today announced that ... U.S. mesh product liability claims and that it is ... claims at reasonable values. Under the agreements, Endo will ... 2017 and continuing through the fourth quarter of 2019. ... Company intends to increase its mesh product liability accrual ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
Breaking Medicine Technology:
(Date:8/16/2017)... , ... August 16, 2017 , ... Paul Vitenas, ... Castle Connolly 2017 Top Doctor. The annual list identifies the nation’s top physicians, in ... Vitenas has made it to the top of Castle Connolly’s coveted ranking. , Castle ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of Infection Control ... cycle, both between patient procedures and before storage, is a requisite practice crucial ... to the prevention of disease transmission and nosocomial infection as cleaning and HLD.” ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery and ... God's love, and all the many ways God shows love to those who ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... an opportunity for men and women to train as hospice volunteers. Volunteers provide ... life-limiting illness. For over 30 years, the agency has trained volunteers to be ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
Breaking Medicine News(10 mins):